Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy

J Garcia-Aguilar, S Patil, MJ Gollub, JK Kim… - Journal of clinical …, 2022 - ascopubs.org
PURPOSE Prospective data on the efficacy of a watch-and-wait strategy to achieve organ
preservation in patients with locally advanced rectal cancer treated with total neoadjuvant …

Quality of life in restorative versus non-restorative resections for rectal cancer: systematic review

S Lawday, N Flamey, GE Fowler, M Leaning, N Dyar… - BJS open, 2021 - academic.oup.com
Background Low rectal cancers could be treated using restorative (anterior resection, AR) or
non-restorative procedures with an end/permanent stoma (Hartmann's, HE; or …

[HTML][HTML] A practical review of watch-and-wait approach in rectal cancer

HK Byun, WS Koom - Radiation Oncology Journal, 2023 - ncbi.nlm.nih.gov
Rectal resection surgery after neoadjuvant treatment has been the mainstay treatment of
locally advanced rectal cancer. However, functional outcomes and quality of life after radical …

Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER PRODIGE 23) …

C Bascoul-Mollevi, S Gourgou, C Borg… - European Journal of …, 2023 - Elsevier
Background Results from the phase 3 PRODIGE 23 study showed that neoadjuvant
chemotherapy (NAC) with mFOLFIRINOX and preoperative chemoradiotherapy improved …

The impact of restorative proctectomy versus permanent colostomy on health-related quality of life after rectal cancer surgery using the patient-generated index

S Robitaille, MF Maalouf, R Penta, TG Joshua… - Surgery, 2023 - Elsevier
Background The impact of bowel dysfunction versus colostomy on quality of life after rectal
cancer surgery is poorly understood. Background To evaluate the quality of life after rectal …

A comparative examination of colorectal cancer burden in European Union, 1990–2019: Estimates from Global Burden of Disease 2019 Study

R Sharma - International Journal of Clinical Oncology, 2022 - Springer
Aim This study examines the burden of colorectal cancer (CRC) in European Union (EU)
countries in the last 3 decades. Methods The data pertaining to CRC burden were procured …

A dynamic clinical calculator for estimating conditional recurrence-free survival after total neoadjuvant therapy for rectal cancer and either surgery or watch-and-wait …

MR Weiser, JF Chou, JK Kim, M Widmar… - JAMA Network …, 2022 - jamanetwork.com
Importance The risk of recurrence in patients with locally advanced rectal cancer has
historically been determined after surgery, relying on pathologic variables. A growing …

The evolving landscape of immunotherapy in locally advanced rectal cancer patients

MM Germani, M Carullo, A Boccaccino, V Conca… - Cancers, 2022 - mdpi.com
Simple Summary At the last 2022 annual ASCO meeting, impressive results of anti-PD1
activity in clinical stage 2 and 3 microsatellite instable rectal cancer patients have been …

Long-term outcomes in a retrospective cohort of patients with rectal cancer with complete response after total neoadjuvant therapy: a propensity-score weighted …

J Wang, L Zhang, M Wang, J Zhang… - Therapeutic …, 2023 - journals.sagepub.com
Background: The watch-and-wait (W&W) strategy is a novel treatment option for patients with
rectal cancer who have a strong desire for organ preservation. The study aimed to explore …

Effect of biofeedback therapy during temporary stoma period in rectal cancer patients: A prospective randomized trial

HM Cho, H Kim, RN Yoo, G Kim, BH Kye - Journal of Clinical Medicine, 2021 - mdpi.com
Background: This prospective randomized controlled study was designed to evaluate the
effect of biofeedback therapy (BFT) during temporary stoma period to prevent defecation …